HSBC HOLDINGS (00005) Completes Share Buyback, Cumulatively Repurchases Approximately 48.6571 Million Shares
HSBC HOLDINGS (00005) announced that on September 28, 2026, it purchased 911,200 shares from BNP Paribas Financial Markets SNC at a volume-weighted average price of HKD 159.5951 per share.
HSBC HOLDINGS (00005) announced that on September 28, 2026, it purchased 911,200 shares from BNP Paribas Financial Markets SNC at a volume-weighted average price of HKD 159.5951 per share.
Following this purchase, the buyback has been completed. Since the commencement of the buyback, the company has repurchased approximately 31,735,500 ordinary shares from the UK location at a volume-weighted average price of GBP 15.1909 per ordinary share, and 16,921,600 ordinary shares from the Hong Kong Stock Exchange at a volume-weighted average price of HKD 161.2887 per ordinary share, for cancellation, with a total consideration of approximately USD 1 billion.
Related Articles

CARSGEN-B (02171): First patient infusion completed for CT1190B in China Phase I registrational clinical trial

HUTCHMED (00013) announces submission of a U.S. New Drug Application for ORPATHYS (savolitinib) in combination with TAGRISSO (osimertinib) for the treatment of MET-driven EGFR-mutated lung cancer

ASCLETIS-B(01672) Announces Positive Results from the 28-Day Proof-of-Concept Clinical Study in the United States of ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor, for the Treatment of Plaque Psoriasis
CARSGEN-B (02171): First patient infusion completed for CT1190B in China Phase I registrational clinical trial

HUTCHMED (00013) announces submission of a U.S. New Drug Application for ORPATHYS (savolitinib) in combination with TAGRISSO (osimertinib) for the treatment of MET-driven EGFR-mutated lung cancer

ASCLETIS-B(01672) Announces Positive Results from the 28-Day Proof-of-Concept Clinical Study in the United States of ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor, for the Treatment of Plaque Psoriasis






